Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
InhaleRx Limited ( (AU:IRX) ) has shared an announcement.
InhaleRx Limited has reaffirmed its commitment to corporate governance by aligning with the ASX Corporate Governance Council Principles and Recommendations. The company has implemented a comprehensive governance framework, including a Board Charter and various policies such as Anti-Bribery, Risk Management, and Diversity. While the company has not yet set measurable objectives for gender diversity, it plans to do so as it grows, indicating a forward-looking approach to inclusivity.
More about InhaleRx Limited
InhaleRx Limited operates within the healthcare industry, focusing on the development and distribution of inhalation-based therapeutic products. The company is committed to maintaining high standards of corporate governance, adhering to the ASX Corporate Governance Council Principles and Recommendations.
YTD Price Performance: -32.50%
Average Trading Volume: 154,894
Technical Sentiment Signal: Buy
Current Market Cap: A$5.76M
See more insights into IRX stock on TipRanks’ Stock Analysis page.